Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 986-994

  Pong, Kevin ^a   Xu, Ren Y ^a   Beck, Klaus D ^a   Zhang, T J ^a   Louis, Jean Claude ^a  

^a AMGEN INC   (United States)

Author keywords

Dopaminergic neurons; Glial cell line derived neurotrophic factor; K 252b; Neurotrophic factors; Phosphorylation; Ret protein tyrosine kinase

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; DOPAMINERGIC NERVE CELL; FOREBRAIN; GLIA CELL; GROWTH REGULATION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; RAT;

ANIMALIA;

EID: 0030843882     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69030986.x     Document Type: Article

References (64)

1. Avantaggiato V., Dathan N. A., Grieco M., Fabien N., Lazzaro D., Fusco A., Simeone A., and Santoro M. (1994) Developmental expression of the ret protooncogene. Cell Growth Differ. 5, 305-311.
2. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., and Hefti F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
3. Bothwell M. (1995) Functional interactions of neurotrophins and neurotrophin receptors. Anna. Rev. Neurosci. 18, 223-253.
4. Buj-Bello A., Buchman V. L., Horton A., Rosenthal A., and Davies A. M. (1995) GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 15, 821-828.
5. Choi-Lundberg D. L. and Bohn M. C. (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev. Brain Res. 85, 80-88.
6. Davies A. M. (1994) The role of neurotrophins in the developing nervous system. J. Neurobiol. 25, 1334-1348.
7. Derynck R. (1988) Transforming growth factor alpha. Cell 54, 593-595.
8. Derynck R., Jarrett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian R. K., Roberts A. B., Sporn M. B., and Goeddel D. V. (1985) Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316, 701-705.
9. Derynck R., Lindquist P. B., Lee A., Wen D., Tamm J., Graycar J. L., Rhee L., Mason A. J., Miller D. A., Coffey R. J., Moses H. L., and Chen E. Y. (1988) A new type of transforming growth factor-β, TGF-β3. EMBO J. 7, 3737-3743.
10. Durbec P., Marcos-Gutierrez C. V., Kilkenny C., Grigoriou M., Wartiowaara K., Suvanto P., Smith D., Ponder B., Costantini F., Saarma M., Sariola H., and Pachnis V. (1996) GDNF signalling through the Ret receptor tyrosine kinase. Nature 381, 789-793.
11. Ehrlich Y. H., Davis T. B., Bock E., Kornecki E., and Lenox R. H. (1986) Ecto-protein kinase activity on the external surface of neural cells. Nature 320, 67-70.
12. Eide R., Cao Y., Cintra A., Crelje T. C., Pelto-Huikko M., Junttila T., Fuxe K., Pettersson R. F., and Hokfelt T. (1991) Prominent expression of acidic fibroblast growth factor in motor and sensory neurons. Neuron 7, 349-364.
13. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., and Gerhardt G. A. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
14. Gotz R., Koster R., Winkler C., Raulf F., Lottspeich F., Schartl M., and Thoenen H. (1994) Neurotrophin-6 is a new member of the nerve growth factor family. Nature 372, 266-269.
15. Hallbook F., Ibanez C. F., and Persson H. (1991) Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6, 845-858.
16. Hashimoto S. (1988) K-252a, a potent protein kinase inhibitor, blocks nerve growth factor-induced neurite outgrowth and changes in phosphorylation of proteins in PC12h cells. J. Cell Biol. 107, 1531-1539.
17. Hefti F. (1994) Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25, 1418-1435.
18. Henderson C. E. (1996) Role of neurotrophic factors in neuronal development. Curr. Neurobiol. 6, 64-70.
19. Henderson C. E., Phillips H. S., Pollack R. A., Davies A. M., Lemeulie C., Armanini M. P., Simpson L. C., Moffet B., Vandlen R. A., Koliatsos V. E., and Rosenthal A. (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062-1064.
20. Hoffer B. J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.-F. H., and Gerhardt G. A. (1994) Glial cell line-derived neurotrophic factor reversed toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182, 107-111.
21. Hohn A., Leibrock J., Bailey K., and Barde Y. A. (1990) Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344, 339-341.
22. Ikeda I., Ishizaka Y., Tahira T., Suzuki T., Onda M., Sugimura T., and Nagao M. (1990) Specific expression of the ret protooncogene in human neuroblastoma cell lines. Oncogene 5, 1291-1296.
23. Isono F., Widmer H. R., Hefti F., and Knüsel B. (1994) Epidermal growth factor induces PC12 cell differentiation in the presence of the protein kinase inhibitor K-252a. J. Neurochem. 63, 1235-1245.
24. Jing S., Wen D., Yu Y., Holst P. L., Luo Y., Fang M., Tamir R., Antonio L., Hu Zheng Cupples R., Louis J.-C., Hu S., Altrock B. W., and Fox G. M. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 85, 1113-1124.
25. Kase H., Iwahashi K., Nakanishi S., Matsuda Y., Yamada K., Takahashi M., Murakata C., Sato A., and Kaneko M. (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142, 436-440.
26. Kearns C. M. and Gash D. M. (1995) GDNF protects nigral dopaminergic neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104-111.
27. Knüsel B. and Hefti F. (1991) K-252b is a selective and nontoxic inhibitor of nerve growth factor action on cultured brain neurons. J. Neurochem. 57, 955-962.
28. Knüsel B. and Hefti F. (1992) K-252 compounds: modulators of neurotrophin signal transduction. J. Neurochem. 59, 1987-1996.
29. Knüsel B., Michel P. P., Schwaber J., and Hefti F. (1990) Selective and non-selective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulinlike growth factors I and II. J. Neurosci. 10, 558-570.
30. Knüsel B., Kaplan D. R., Winslow J. W. Rosenthal A., Burton L. E., Beck K. D., Rabin S., Nikolics K., and Hefti F. (1992a) K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3. J. Neurochem. 59, 715-722.
31. Knüsel B., Rabin S., Widmer H. R., Hefti F., and Kaplan D. R. (1992b) Neurotrophin-induced trk receptor phosphorylation and cholinergic neuron response in primary cultures of embryonic rat brains. Neuroreport 3, 885-888.
32. Kotzbauer P. T., Lampe P. A., Heuckeroth R. O., Golden J. P., Creedon D. J., Johnson E. M., and Milbrandt J. (1996) Neurturin, a relative of glial cell line-derived neurotrophic factor. Nature 384, 467-470.
33. Lapchak P. A., Jiao S., Miller P. J., Williams L. R., Cummins V., Inouye G., Matheson C. R., and Yan Q. (1996a) Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases. Cell Tissue Res. 286, 191-207.
34. Lapchak P. A., Miller P. J., Jiao S., Araujo D. M., Hilt D., and Collins F. (1996b) Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease. Neurodegeneration 5, 197-205.
35. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., and Barde Y. A. (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341, 149-152.
36. Levi-Montalcini R. (1987) The nerve growth factor: thirty-five years later. Science 237, 1154-1162.
37. Lin L.-F. H., Mismer D., Lile J. D., Armes L. G., Butler E. T., Vannice J. L., and Collins F. (1989) Purification, cloning, and expression of ciliary neurotrophic factor (CNTF). Science 246, 1023-1025.
38. Lin L.-F. H., Doherty D. H., Lile J. D., Bektesh S., and Collins F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
39. NTR. J. Neurochem. 68, 88-94.
40. Massague J. (1996) Crossing receptor boundaries. Nature 382, 29-30.
41. Matsuda Y. and Fukuda J. (1988) Inhibition by K-252a, a new inhibitor of protein kinase, of nerve growth factor-induced neurite outgrowth of chick embryo dorsal root ganglion cells. Neurosci. Lett. 87, 11-17.
42. Morrison R. S., Keating R. F., and Moskal J. R. (1988) Basic fibroblast growth factor and epidermal growth factor exert differential trophic effects on CNS neurons. J. Neurosci. Res. 21, 71-79.
43. Nagashima K., Nakanishi S., and Matsuda Y. (1991) Inhibition of nerve growth factor-induced neunte outgrowth of PC12 cells by a protein kinase inhibitor which does not permeate the cell membrane. FEBS Lett. 293, 119-123.
44. Nosrat C. A., Tomac A., Lindqvist E., Lindskog S., Humpel C., Stromberg I., Ebendal T., Hoffer B. J., and Olson L. (1996) Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res. 286, 191-207.
45. Oppenheim R. W. (1991) Cell death during development of the nervous system. Annu. Rev. Neurosci. 14, 453-501.
46. Oppenheim R. W., Houenou L. J., Johnson J. E., Lin L.-F. H., Li L., Lo A. C., Newsome A. L., Prevette D. M., and Want S. (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373, 344-346.
47. Prochiantz A. M., Daguet C., Herbet A., and Glowinsky J. (1981) Specific stimulation of in vitro maturation of mesencephalic dopaminergic neurons by striatal membranes. Nature 293, 570-572.
48. Riaz S. S. and Tomlinson D. R. (1996) Neurotrophic factors in peripheral neuropathies: pharmacological strategies. Prog. Neurobiol. 49, 125-143.
49. Rosenthal A., Goeddel D. V., Nguyen T., Martin E., Burton L. E., Shih A., Laramee G. R., Wurm F., Mason A., Nikolics K., and Winslow J. W. (1991) Primary structure and biological activity of human brain-derived neurotrophic factor. Endocrinology 129, 1289-1294.
50. Ross A. H., McKinnon C. A., Daou M.-C., Ratliff K., and Wolf D. E. (1995) Differential biological effects of K252 kinase inhibitors are related to membrane solubility but not to permeability. J. Neurochem. 65, 2748-2756.
51. Santoro M., Rosati R., Grieco M., Berlingieri M. T., Colucci-D'Amato G. L., De Franciscis V., and Fusco A. (1990) The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene 5, 1595-1598.
52. Schatzl H. M. (1995) Neurotrophic factors: ready to go? Trends Neurosci. 18, 463-464.
53. Schuchardt A., D'Agatl V., Larsson-Blomberg L., Costantinl F., and Pachnis V. (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367, 380-383.
54. Seyedin S. M., Thompson A. Y., Bentz H., Rosen D. M., McPherson J. M., Conti A., Siegel N. R., Galluppi G. R., and Piez K. A. (1986) Cartilage-inducing factor A: apparent identity to transforming growth factor-β. J. Biol. Chem. 261, 5693-5695.
55. Tomac A., Lindqvist E., Lin L.-F. H., Ogren S. O., Young D., Hoffer B. J., and Olson L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
56. Treanor J. J. S., Goodman L., de Sauvague F., Stone D. M., Poulsen K. T., Beck C. D., Gray C., Armanini M. P., Pollock R. A., Hefti F., Phillips H. S., Goddard A., Moore M. W., Buj-Bello A., Davies A. M., Asai N., Takahashi M., Vandlen R., Henderson C. E., and Rosenthal A. (1996) Characterization of a multi-component receptor for GDNF. Nature 382, 80-83.
57. Trupp M., Ryden M., Jornvall H., Funakoshi H., Timmusk T., Arenas E., and Ibanez C. F. (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130, 137-148.
58. Trupp M., Arenas E., Fainsilber M., Nilsson A.-S., Sieber B.-A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumae U., Sariola H., Saarma M., and Ibanez C. F. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 785-789.
59. Walicke P., Cowan W. M., Ueno N., Baird A., and Guillemin R. (1986) Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. Natl. Acad. Sci. USA 83, 3012-3016.
60. Wen D., Suggs S., Devarajan K., Liu N., Cupples R., Luo Y., Janssen A., Ben-Barruch N., Trollinger D., Jacobsen V., Meng T., Lu H., Hu S., Chang D., Yanigahara D., Koski R., and Yarden Y. (1994) Structural and functional aspects of the multiplicity of Neu differentiation factors. Mol. Cell. Biol. 14, 1909-1919.
61. Widmer H. R., Ohsawa F., Knüsel B., and Hefti F. (1993a) Down-regulation of phosphatidylinositol response to BDNF and NT-3 in cultures of cortical neurons. Brain Res. 614, 325-334.
62. Widmer H. R., Kaplan D. R., Rabin S. J., Beck K. D., Hefti F., and Knüsel B. (1993b) Rapid phosphorylation of phospholipase Cγ1 by brain-derived neurotrophic factor and neurotrophin-3 in cultures of embryonic rat cortical neurons. J. Neurochem. 60, 2111-2123.
63. Wu C. F. and Howard B. D. (1995) K252a-potentiation of EGF-induced neurite outgrowth from PC12 cells is not mimicked or blocked by other protein kinase activators or inhibitors. Dev. Brain Res. 86, 217-226.
64. Yan Q., Matheson C. R., and Lopez O. T. (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341-344.